Growth Metrics

Marimed (MRMD) Cash from Operations (2016 - 2025)

Marimed has reported Cash from Operations over the past 13 years, most recently at 3429000.0 for Q4 2025.

  • Quarterly Cash from Operations rose 930.27% to 3429000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7695000.0 through Dec 2025, up 13.41% year-over-year, with the annual reading at 7695000.0 for FY2025, 13.41% up from the prior year.
  • Cash from Operations was 3429000.0 for Q4 2025 at Marimed, up from 2676000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 10833000.0 in Q2 2021 and troughed at 6261000.0 in Q2 2022.
  • The 5-year median for Cash from Operations is 3197500.0 (2024), against an average of 3277800.0.
  • Year-over-year, Cash from Operations skyrocketed 1760.26% in 2021 and then plummeted 157.8% in 2022.
  • A 5-year view of Cash from Operations shows it stood at 7607000.0 in 2021, then crashed by 77.17% to 1737000.0 in 2022, then skyrocketed by 86.18% to 3234000.0 in 2023, then crashed by 112.77% to 413000.0 in 2024, then skyrocketed by 930.27% to 3429000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Cash from Operations are 3429000.0 (Q4 2025), 2676000.0 (Q3 2025), and 297000.0 (Q2 2025).